iTRAQ and PRM-Based Proteomic Analysis Provides New Insights into Mechanisms of Response to Triple Therapy in Patients with Rheumatoid Arthritis

BACKGROUND: Approximately 30% of patients with rheumatoid arthritis (RA) respond poorly to combination therapy of multiple drugs. The molecular mechanisms of different responses to methotrexate + leflunomide + infliximab therapy in patients with RA were explored in this study. METHODS: Infliximab wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jian, Li, Shu, Ge, Yan, Kang, Jin, Liao, Jia-fen, Du, Jin-feng, Tian, Jing, Xie, Xi, Li, Fen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694403/
https://www.ncbi.nlm.nih.gov/pubmed/34955646
http://dx.doi.org/10.2147/JIR.S340351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694403/
https://www.ncbi.nlm.nih.gov/pubmed/34955646
http://dx.doi.org/10.2147/JIR.S340351

Ejemplares similares